HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Hypolipoproteinemia and secondary role of atherosclerosis in the development of ischemic heart disease in patients with polycythemia vera].

Abstract
Relationship between presence of coronary heart disease (CHD), coronary risk factors (parameters of lipid transport system and hypertension) and disturbances of microcirculation was studied in patients with myeloproliferative blood disease Polycythemia Vera (PV). Probability of tissue (including blood vessel wall) cholesterol accumulation was estimated by measurement of its content in skin surface layers. PV patients (n=55, including 27 patients with CHD) had predominant hypolipoproteinemia with normal proportion of various lipoprotein classes. Absence of substantial increase of skin surface cholesterol content both in patients with and without CHD was considered to be a sign of low probability of the presence of severe atherosclerotic processes. However patients with CHD had substantially more pronounced disturbances of microcirculation. Basing on these data the authors suggest that CHD in PV patients had non-lipoprotein genesis and present discussion of alternative mechanisms of vascular changes.
AuthorsT I Torkhovskaia, E S Fortinskaia, G N Gorokhovskaia, V N Soboleva, Zh I Kliuchnikova, N A Nikitina, E M Khalilov, A I Martynov
JournalKardiologiia (Kardiologiia) Vol. 45 Issue 1 Pg. 18-21 ( 2005) ISSN: 0022-9040 [Print] Russia (Federation)
PMID15699934 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Cholesterol
Topics
  • Adult
  • Aged
  • Cholesterol (blood, metabolism)
  • Coronary Artery Disease (blood, complications)
  • Coronary Circulation
  • Coronary Vessels (metabolism)
  • Female
  • Humans
  • Hypolipoproteinemias (blood, complications)
  • Male
  • Microcirculation
  • Middle Aged
  • Myocardial Ischemia (blood, etiology)
  • Polycythemia Vera (blood, complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: